Bipolar Disorder Clinical Trial
Official title:
A Genetic Family Cohort Study of Bipolar Disorder in Chinese Han Population
This study intends to find out the pathogenic genes of bipolar disorder by collecting the two-phase family of Chinese Han population with the large sample using a family cohort study design, combined with the new generation of high-throughput sequencing technology and Genome-Wide Association Studies (GWAS), Proteomics, bioinformatics analysis, etc., which is expected to be clarified at the genetic level. The pathogenesis of bipolar disorder. At the same time, the investigators will conduct a five-year follow-up of cognitive function, brain function imaging and other major clinical symptoms in patients with bipolar disorder in the core family, and to explore familial bipolar disorder and sporadic biphasic. Differences in the clinical features of the disorder, in order to explore sensitive and specific biomarkers from a multidimensional perspective (cognitive function, brain imaging, genetic features, clinical features, etc.), which may contribute to bipolar disorder in the future. Accurate diagnosis and early identification and prevention have important scientific significance and clinical diagnosis and treatment significance.
Bipolar disorder (BD) is a serious, complex, family-grafting mental illness. Studies have
shown that genetic factors may be the dominant factor in the pathogenesis of bipolar
disorder, thus, it is worth looking forward to getting started and clarifying the etiology of
bipolar disorder from a genetic perspective. However, earlier genetic studies such as linkage
analysis, genetic mutation detection (preferred candidate genes), and recent genetic studies
(no need to presuppose candidate genes) such as Whole Genome Sequencing (WGS), whole genome
GWAS and Whole-exome sequencing (WES) failed to identify any biogenic disorder gene or
chromosomal region that plays a major role in, which may be related to the synergy of
population heterogeneity, insufficient sample size or coordination effect caused by common
mutations.
As a familial, highly heritable psychiatric disease, the literature suggests that the
pathogenic genes of bipolar disorder may be directly derived from the intergenerational
transmission of rare mutations in family members, and these rare variants are more likely to
be predicated from the family. It has been found that the family has a higher frequency and
is more susceptible to detecting susceptibility genes for bipolar disorder. Therefore, the
family research design combined with WGS, GWAS and other advanced genetic research methods
can reduce the unnecessary sample size, eliminate the confounding factors of the population,
and more easily capture the potential genes of bipolar disorder.
However, at present, there are few reports of foreign bipolar disorder family and the results
are not consistent. There is no research report on the large sample family of Chinese Han
population in China. Therefore, it is necessary to expand the family sample size and combine
with new genetic research methods in the Han population. explore. Therefore, this study
intends to find out the pathogenic genes of bipolar disorder by collecting the two-phase
family of Chinese Han population with the large sample using a family cohort study design,
combined with the new generation of high-throughput sequencing technology and GWAS,
Proteomics, bioinformatics analysis, etc., which is expected to be clarified at the genetic
level. The pathogenesis of bipolar disorder. At the same time, the investigators will conduct
a five-year follow-up of cognitive function, brain function imaging and other major clinical
symptoms in patients with bipolar disorder in the core family, and to explore familial
bipolar disorder and sporadic biphasic. Differences in the clinical features of the disorder,
in order to explore sensitive and specific biomarkers from a multidimensional perspective
(cognitive function, brain imaging, genetic features, clinical features, etc.), which may
contribute to bipolar disorder in the future. Accurate diagnosis and early identification and
prevention have important scientific significance and clinical diagnosis and treatment
significance.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT02855762 -
Targeting the Microbiome to Improve Clinical Outcomes in Bipolar Disorder
|
N/A | |
Recruiting |
NCT05915013 -
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
|
Phase 1 | |
Recruiting |
NCT05206747 -
Ottawa Sunglasses at Night for Mania Study
|
N/A | |
Completed |
NCT02513654 -
Pharmacokinetics, Safety and Tolerability of Repeat Dosing Lamotrigine in Healthy Chinese Subjects
|
Phase 1 | |
Recruiting |
NCT06313918 -
Exercise Therapy in Mental Disorders-study
|
N/A | |
Completed |
NCT02304432 -
Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine
|
Early Phase 1 | |
Recruiting |
NCT06197048 -
Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder
|
N/A | |
Completed |
NCT03497663 -
VIA Family - Family Based Early Intervention Versus Treatment as Usual
|
N/A | |
Completed |
NCT04284813 -
Families With Substance Use and Psychosis: A Pilot Study
|
N/A | |
Completed |
NCT02212041 -
Electronic Cigarettes in Smokers With Mental Illness
|
N/A | |
Recruiting |
NCT05030272 -
Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings
|
N/A | |
Recruiting |
NCT04298450 -
ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention
|
N/A | |
Active, not recruiting |
NCT03641300 -
Efficacy of Convulsive Therapies for Bipolar Depression
|
N/A | |
Not yet recruiting |
NCT04432116 -
Time and Virtual Reality in Schizophrenia and Bipolar Disorder
|
N/A | |
Terminated |
NCT02893371 -
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
|
||
Terminated |
NCT02909504 -
Gao NARASD Lithium Study
|
Phase 4 | |
Completed |
NCT02970721 -
Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder
|
||
Recruiting |
NCT03088657 -
Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study
|
||
Recruiting |
NCT02481245 -
BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study
|
Phase 2 |